Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Rangering i aksjer #27022
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Aksjekurs
$0.16240909
Sist synkronisert: 2025-03-04
Markedsverdi
$35.68M
Endring (1 dag)
0.27%
Endring (1 år)
0.00%
Land
CN
Handel Dali Pharmaceuticalco.,Ltd (603963)

Kategori

Antall utestående aksjer for Dali Pharmaceuticalco.,Ltd (603963)
Antall utestående aksjer per September 2024: 219.70M
Ifølge Dali Pharmaceuticalco.,Ltd sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 219.70M. Ved slutten av December 2022 hadde selskapet 219.70M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Dali Pharmaceuticalco.,Ltd (603963) fra 2012 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 219.70M -1.29%
2023 222.57M 1.31%
2022 219.70M 0.00%
2021 219.70M 0.00%
2020 219.70M 0.00%
2019 219.70M -5.14%
2018 231.61M 54.15%
2017 150.25M -8.69%
2016 164.55M 20.24%
2015 136.85M 24.49%
2014 109.93M 0.04%
2013 109.89M -0.06%
2012 109.95M 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter